Zivo Bioscience, Inc. ZIVO US Equity☆

Zivo Bioscience, Inc. (OTC: ZIVO), an SEC filer in Biological Products, (No Diagnostic Substances), closed at $4.27, +0.0%, on 2026-08-28, with a market cap of $17M as of 2026-08-26 and a net margin of -8513.4%. Institutional ownership, earnings history and filed financials are on the tabs below.